ND BioSciences None

ND BioSciences is a biotechnology company that focuses on developing innovative technologies, solutions, tools, assays, and services for early diagnostics and therapies for neurodegenerative diseases. They are a spinoff from the Swiss Federal Institute of Technology in Lausanne (EPFL) and specialize in developing next-generation therapeutics for NDs, such as Parkinson\u2019s and Alzheimer\u2019s Disease. Their therapeutic development programs are enabled by an integrated suite of tools.

Invests into

Connections

Estimated Revenue: P11,294
Register and Claim Ownership